Inherited vitreoretinopathy
MONDO:002024671 clinical trials for this condition and its sub-types, 0 tagged with Inherited vitreoretinopathy itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Inherited vitreoretinopathy
-
Vitreoretinal degeneration 0 trials · 45 incl. sub-types
9 sub-types
- Exudative vitreoretinopathy 1 trial · 35 incl. sub-types Sub-types →
- Stickler syndrome 2 trials · 4 incl. sub-types Sub-types →
- X-linked retinoschisis 4 trials
- Enhanced S-cone syndrome 2 trials Sub-types →
- Wagner disease 1 trial
- BEST1-related vitreoretinochoroidopathy 0 trials Sub-types →
- CAPN5-related vitreoretinopathy 0 trials
- Knobloch syndrome 0 trials Sub-types →
- Snowflake vitreoretinal degeneration 0 trials
-
Congenital vitreoretinal dysplasia 0 trials · 9 incl. sub-types
9 sub-types
- Trisomy 13 4 trials Sub-types →
- Incontinentia pigmenti 3 trials
- Coats disease 2 trials
- Coats plus syndrome 0 trials Sub-types →
- Norrie disease 0 trials
- Osteoporosis-pseudoglioma syndrome 0 trials
- Persistent hyperplastic primary vitreous 0 trials Sub-types →
- Retinal capillary malformation 0 trials
- Spondylo-ocular syndrome 0 trials
-
Vitreous detachment 5 trials
-
NDP-related vitreoretinopathy 0 trials
2 sub-types
- Norrie disease 0 trials
- Exudative vitreoretinopathy 2, X-linked 0 trials
-
TSPAN12-related vitreoretinopathy 0 trials
1 sub-type
Most studied deeper sub-types
-
Tiny doses of avastin tested against laser for preemie eye disease
Disease control Stopped earlyThis study tested a low dose of the drug bevacizumab (Avastin) against standard laser treatment for retinopathy of prematurity, an eye disease that can blind premature infants. Sixteen babies with severe disease were enrolled. The goal was to see if the drug could control the dis…
Phase 3 • Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
VR headsets tested as a possible treatment for blindness
Disease control Stopped earlyThis study tested whether using a virtual reality headset for one-hour sessions could help regenerate damaged optic nerves and improve vision in people with glaucoma or other retinal diseases. The idea came from promising results in rodents. However, the trial was terminated earl…
Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Eye injections tested to save sight in rare coats disease
Disease control Stopped earlyThis study tested whether anti-VEGF injections into the eye could help treat Coats disease, a rare condition that causes abnormal blood vessels and fluid buildup in the retina, potentially leading to blindness. The trial included 18 people with early-stage Coats disease who had n…
Phase 3 • Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC